Nagy Habib
Fondateur chez EMcision Ltd.
Profil
Nagy Habib is the founder of EMcision Ltd.
(founded in 1999) and MiNA Therapeutics Ltd.
(founded in 2008), where he holds the titles of Chairman & Medical Director and Chairman, Head-Research & Development respectively.
Currently, Dr. Habib holds the position of Chairman-Surgery at Imperial College London, Director at Mina (Holdings) Ltd.
(since 2014), and Principal at Imperial College Healthcare NHS Trust.
In the past, Dr. Habib worked as a Supervisory Investment Committee Member at Deepbridge Capital LLP.
Postes actifs de Nagy Habib
| Sociétés | Poste | Début |
|---|---|---|
EMcision Ltd.
 EMcision Ltd. Medical SpecialtiesHealth Technology EMcision Ltd. develops medical devices. Its products include Habib EndoHPB, Endoblate, VesCoag, VesOpen, Percutaneous HPB, and EUS RFA. The firm's products are used for laparoscopic, vascular and endoscopic surgeries. It serves in the area of research and development and commercial sectors. The company was founded by Nagy Habib on June 16, 1999 and is headquartered in London, the United Kingdom. | Fondateur | 16/06/1999 |
| Imperial College London | Corporate Officer/Principal | - |
Imperial College Healthcare NHS Trust
 Imperial College Healthcare NHS Trust Hospital/Nursing ManagementHealth Services Imperial College Healthcare NHS Trust is a non-profit organization which provides community and healthcare services. It offers cardiology, endocrinology, melanoma, maternity ultrasound, maternal medicine, and major trauma center. The organization was founded on October 1, 2007 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014. | Directeur/Membre du Conseil | 17/12/2014 |
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Fondateur | 01/01/2008 |
Anciens postes connus de Nagy Habib
| Sociétés | Poste | Fin |
|---|---|---|
Deepbridge Capital LLP
 Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Membre du Comité d'Investissement | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
EMcision Ltd.
EMcision Ltd. Medical SpecialtiesHealth Technology EMcision Ltd. develops medical devices. Its products include Habib EndoHPB, Endoblate, VesCoag, VesOpen, Percutaneous HPB, and EUS RFA. The firm's products are used for laparoscopic, vascular and endoscopic surgeries. It serves in the area of research and development and commercial sectors. The company was founded by Nagy Habib on June 16, 1999 and is headquartered in London, the United Kingdom. | Health Technology |
Imperial College Healthcare NHS Trust
Imperial College Healthcare NHS Trust Hospital/Nursing ManagementHealth Services Imperial College Healthcare NHS Trust is a non-profit organization which provides community and healthcare services. It offers cardiology, endocrinology, melanoma, maternity ultrasound, maternal medicine, and major trauma center. The organization was founded on October 1, 2007 and is headquartered in London, the United Kingdom. | Health Services |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014. | Finance |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Deepbridge Capital LLP
Deepbridge Capital LLP Investment ManagersFinance Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK. | Finance |
